Bofanglutide
GZR18-BWM-303
Gan & Lee Pharmaceuticals · Phase 3 · Recruiting · Enrollment 500
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Placebo | Obesity or overweight | n/r | 2 | n/r | n/r |
| GZR18 injection Dose1 | Obesity or overweight | n/r | 2 | n/r | n/r |
| GZR18 injection Dose2 | Obesity or overweight | n/r | 2 | n/r | n/r |
| GZR18 injection Dose3 | Obesity or overweight | n/r | 2 | n/r | n/r |